Literature DB >> 25596900

Factors associated with quality of life in active childhood epilepsy: a population-based study.

Colin Reilly1, Patricia Atkinson2, Krishna B Das3, Richard F M Chin4, Sarah E Aylett5, Victoria Burch6, Christopher Gillberg7, Rod C Scott8, Brian G R Neville9.   

Abstract

BACKGROUND: Improving health-related quality of life (HRQOL), rather than just reducing seizures, should be the principal goal in comprehensive management of childhood epilepsy. There is a lack of population-based data on predictors of HRQOL in childhood epilepsy.
METHODS: The Children with Epilepsy in Sussex Schools (CHESS) study is a prospective, population-based study involving school-aged children (5-15 years) with active epilepsy (on one or more AED and/or had a seizure in the last year) in a defined geographical area in the UK. Eighty-five of 115 (74% of eligible population) children underwent comprehensive psychological assessment including measures of cognition, behaviour, and motor functioning. Parents of the children completed the Quality of Life in Childhood Epilepsy (QOLCE).Clinical data on eligible children was extracted using a standardised pro forma. Linear regression analysis was undertaken to identify factors significantly associated with total Quality of Life in this population.
RESULTS: Factors independently significantly associated (p < .05) with total QOLCE scores were seizures before 24 months, cognitive impairment (IQ < 85), anxiety, and parent reported school attendance difficulty. These factors were also significantly associated with total QOLCE when children with IQ < 50 were excluded from analysis.
CONCLUSIONS: The majority of factors associated with parent reported HRQOL in active childhood epilepsy are related to neurobehavioural and/or psychosocial aspects of the condition.
Copyright © 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behaviour; Cognition; Epilepsy; Quality of life

Mesh:

Year:  2015        PMID: 25596900     DOI: 10.1016/j.ejpn.2014.12.022

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  8 in total

1.  Trajectories of Health-Related Quality of Life Among Children With Newly Diagnosed Epilepsy.

Authors:  Kristin A Loiselle; Rachelle R Ramsey; Joseph R Rausch; Avani C Modi
Journal:  J Pediatr Psychol       Date:  2016-03-27

2.  Psychometric Properties of the Turkish Version of the Epilepsy Module of the KINDL Quality of Life Scale.

Authors:  Dilek Ergin; Selin Demirbağ; Erhan Eser; Muzaffer Polat; Hakan Baydur
Journal:  Noro Psikiyatr Ars       Date:  2021-11-02       Impact factor: 1.066

Review 3.  Network science for the identification of novel therapeutic targets in epilepsy.

Authors:  Rod C Scott
Journal:  F1000Res       Date:  2016-05-16

Review 4.  Psychosocial aspects of epilepsy: a wider approach.

Authors:  Marco Mula; Josemir W Sander
Journal:  BJPsych Open       Date:  2016-08-17

5.  Subcortical nuclei volumes are associated with cognition in children post-convulsive status epilepticus: Results at nine years follow-up.

Authors:  Kyle H Bennett; Suresh S Pujar; Marina M Martinos; Christopher A Clark; Michael Yoong; Rod C Scott; Richard F M Chin
Journal:  Epilepsy Behav       Date:  2020-06-08       Impact factor: 2.937

6.  Factors associated with reported challenging behavior in young people with epilepsy and neurodevelopmental problems: Data from a specialist epilepsy center.

Authors:  Colin Reilly; Rod C Scott
Journal:  Epilepsia Open       Date:  2016-11-25

7.  Child and parental sleep in young children with epilepsy: A population-based case-control study.

Authors:  Colin Reilly; Patricia Atkinson; Ayesha Memon; Chloe Jones; Lyvia Dabydeen; J Helen Cross; Krishna B Das; Christopher Gillberg; Brian G R Neville; Rod C Scott
Journal:  Epilepsia Open       Date:  2018-07-08

8.  Factors for cognitive impairment in adult epileptic patients.

Authors:  Lei Wang; Shenggen Chen; Changyun Liu; Wanhui Lin; Huapin Huang
Journal:  Brain Behav       Date:  2019-12-21       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.